Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors
Clinical trial NCT03721341 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03721341
- Sponsor
- David Palma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-22
- Primary completion
- 2029-01-01
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.